|
- 2019
High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated NanoparticlesDOI: 10.1021/acscentsci.8b00746 Abstract:
|